Elritercept
KER050-MF-301
Phase 2 small_molecule active
Quick answer
Elritercept for Myelofibrosis is a Phase 2 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Myelofibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active